Dengue patients exhibit higher levels of PrM and e antibodies than their asymptomatic counterparts

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Yeo, Adeline Syin Lian ^a   Rathakrishnan, Anusyah ^a   Wang, Seok Mui ^b   Ponnampalavanar, Sasheela ^c   Manikam, Rishya ^c   Sathar, Jameela ^d   Kumari Natkunam, Santha ^e   Sekaran, Shamala Devi ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^c UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^d Ampang Puteri Specialist Hospital Malaysia   (Malaysia)

^e Hospital Tengku Ampuan Rahimah   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; M PROTEIN; NEUTRALIZING ANTIBODY; RECOMBINANT ENVELOPE E PROTEIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANTIGENICITY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION INHIBITION; HUMAN; MAJOR CLINICAL STUDY; PRIMARY INFECTION; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY INFECTION; SEROCONVERSION; SERODIAGNOSIS; SEROTYPING; DNA SEQUENCE; FAMILY SIZE; IMMUNOLOGY; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; VIROLOGY; WESTERN BLOTTING;

DENGUE VIRUS;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BASE SEQUENCE; BLOTTING, WESTERN; DENGUE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAMILY CHARACTERISTICS; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; RESTRICTION MAPPING; SEQUENCE ANALYSIS, DNA;

EID: 84925310732     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/420867     Document Type: Article

References (41)

1. N. R. da Costa Faria, R. M. R. Nogueira, A. M. B. de Filippis et al., "Twenty years of DENV-2 activity in Brazil: molecular characterization and phylogeny of strains isolated from 1990 to 2010, " PLoS Neglected Tropical Diseases, vol. 7, no. 3, Article ID e2095, 2013.
2. S. Bhatt, P. W. Gething, O. J. Brady et al., "The globaldistribution and burden of dengue, " Nature, vol. 496, no. 7446, pp. 504-507, 2013.
3. S. C. Kliks, A. Nisalak, W. E. Brandt, L. Wahl, and D. S. Burke, "Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever, "The American Journal of Tropical Medicine and Hygiene, vol. 40, no. 4, pp. 444-451, 1989.
4. A. Mathew and A. L. Rothman, "Understanding the contribution of cellular immunity to dengue disease pathogenesis, " Immunological Reviews, vol. 225, no. 1, pp. 300-313, 2008.
5. S. B. Halstead, "Pathogenisis of dengue: challenges to molecular biology, " Science, vol. 239, no. 4839, pp. 476-481, 1988.
6. R. Perera and R. J. Kuhn, "Structural proteomics of dengue virus, " Current Opinion in Microbiology, vol. 11, no. 4, pp. 369-377, 2008.
7. M. V. Cherrier, B. Kaufmann, G. E. Nybakken et al., "Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody, " The EMBO Journal, vol. 28, no. 20, pp. 3269-3276, 2009.
8. J. Junjhon, T. J. Edwards, U. Utaipat et al., "Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles, " Journal of Virology, vol. 84, no. 16, pp. 8253-8358, 2010.
9. W. Dejnirattisai, A. Jumnainsong, N. Onsirisakul et al., "Crossreacting antibodies enhance dengue virus infection in humans, " Science, vol. 328, no. 5979, pp. 745-748, 2010.
10. I. A. Rodenhuis-Zybert, H. M. van der Schaar, J. M. da Silva Voorham et al., "Immature dengue virus: a veiled pathogen" PLoS Pathogens, vol. 6, no. 1, Article ID e1000718, 2010.
11. J. T. Roehrig, R. A. Bolin, and R. G. Kelly, "Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica, " Virology, vol. 246, no. 2, pp. 317-328, 1998.
12. Y. Y. Kong, C. H. Thay, T. C. Tin, and S. Devi, "Rapid detection, serotyping and quantitation of dengue viruses by TaqMan realtime one-step RT-PCR, " Journal of Virological Methods, vol. 138, no. 1-2, pp. 123-130, 2006.
13. S. K. Lam, S. Devi, and T. Pang, "Detection of specific IgM in dengue infection, " The Southeast Asian Journal of Tropical Medicine and Public Health, vol. 18, no. 4, pp. 532-538, 1987.
14. D. H. Clarke and J. Casals, "Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses, " The American Journal of Tropical Medicine and Hygiene, vol. 7, no. 5, pp. 561-573, 1958.
15. P. K. Russell, A. Nisalak, P. Sukhavachana, and S. Vivona, "A plaque reduction test for dengue virus neutralizing antibodies, " The Journal of Immunology, vol. 99, no. 2, pp. 285-290, 1967.
16. W. Dengue, Guidelines for Diagnosis, Treatment, Prevention and Control, World Health Organization, Geneva, Switzerland, 2009.
17. M. Montoya, L. Gresh, J. C. Mercado et al., "Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year, " PLoS Neglected Tropical Diseases, vol. 7, no. 8, Article ID e2357, 2013.
18. T. P. Endy, K. B. Anderson, A. Nisalak et al., "Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand, " PLoS Neglected Tropical Diseases, vol. 5, no. 3, article e975, 2011.
19. I.-K. Yoon, A. L. Rothman, D. Tannitisupawong et al., "Underrecognized mildly symptomatic viremic dengue virus infections in rural thai schools and villages, " Journal of Infectious Diseases, vol. 206, no. 3, pp. 389-398, 2012.
20. A. B. Sabin, "Research on dengue during World War II, " The American Journal of Tropical Medicine and Hygiene, vol. 1, pp. 30-50, 1952
21. TDR/WHO, Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control, TDR/WHO, Geneva, Switzerland, 2009.
22. S. J. Thomas, J. Hombach, and A. Barrett, "Scientific consultation on cell mediated immunity (CMI) in dengue and dengue vaccine development, " Vaccine, vol. 27, no. 3, pp. 355-368, 2009.
23. J. L. Kyle, S. J. Balsitis, L. Zhang, P. R. Beatty, and E. Harris, "Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in amouse model, " Virology, vol. 380, no. 2, pp. 296-303, 2008.
24. K. A. Dowd, C. A. Jost, A. P. Durbin, S. S. Whitehead, and T. C. Pierson, "A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus, " PLoS Pathogens, vol. 7, no. 6, Article ID e1002111, 2011.
25. K. A. Dowd and T. C. Pierson, "Antibody-mediated neutralization of flaviviruses: a reductionist view, " Virology, vol. 411, no. 2, pp. 306-315, 2011.
26. T. C. Pierson, Q. Xu, S. Nelson et al., "The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection, " CellHost andMicrobe, vol. 1, no. 2, pp. 135-145, 2007.
27. J. D. Brien, S. K. Austin, S. Sukupolvi-Petty et al., "Genotypespecific neutralization and protection by antibodies against dengue virus type 3, " Journal of Virology, vol. 84, no. 20, pp. 10630-10643, 2010.
28. W. M. P. B. Wahala, E. F. Donaldson, R. de Alwis, M. A. Accavitti-Loper, R. S. Baric, and A. M. de Silva, "Natural strain variation and antibody neutralization of dengue serotype 3 viruses, " PLoS Pathogens, vol. 6, no. 3, Article IDe1000821, 2010.
29. M. Kamionka, "Engineering of therapeutic proteins production in Escherichia coli, " Current Pharmaceutical Biotechnology, vol. 12, no. 2, pp. 268-274, 2011.
30. R. J. Sugrue, T. Cui, Q. Xu, J. Fu, and Y. C. Chan, "Theproduction of recombinant dengue virus E protein using Escherichia coli and Pichia pastoris, " Journal of Virological Methods, vol. 69, no. 1-2, pp. 159-169, 1997.
31. T. N. Athmaram, S. Saraswat, P. Misra et al., "Optimization of Dengue-3 recombinant NS1 protein expression in E. coli and in vitro refolding for diagnostic applications, " Virus Genes, vol. 46, no. 2, pp. 219-230, 2013.
32. P. W. Mason, M. U. Zugel, A. R. Semproni, M. J. Fournier, and T. L. Mason, "The antigenic structure of dengue type 1 virus envelope and NS1 proteins expressed in Escherichia coli, " Journal of General Virology, vol. 71, no. 9, pp. 2107-2114, 1990.
33. F. Megret, J. P. Hugnot, A. Falconar et al., "Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein, " Virology, vol. 187, no. 2, pp. 480-491, 1992.
34. M. J. Cardosa, S. M. Wang, M. S. H. Sum, and P. H. Tio, "Antibodies against prMprotein distinguish between previous infection with dengue and Japanese encephalitis viruses., " BMC Microbiology, vol. 2, article 9, 2002.
35. P. Plevka, A. J. Battisti, J. Junjhon et al., "Maturation of flaviviruses starts from one or more icosahedrally independent nucleation centres, " EMBO Reports, vol. 12, no. 6, pp. 602-606, 2011.
36. S. Nelson, C. A. Jost, Q. Xu et al., "Maturation ofWest Nile virus modulates sensitivity to antibody-mediated neutralization, " PLoS Pathogens, vol. 4, no. 5, Article ID e1000060, 2008.
37. K.-J. Huang, Y.-T. Cheng, Y.-S. Lin et al., "Anti-prMantibody as an autoantibody in dengue virus infection, " American Journal of Infectious Diseases, vol. 4, no. 1, pp. 60-68, 2008.
38. C.-Y. Lai, W.-Y. Tsai, S.-R. Lin et al., "Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II, " Journal of Virology, vol. 82, no. 13, pp. 6631-6643, 2008.
39. A. K. I. Falconar, "Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E andM) proteins, " Archives of Virology, vol. 144, no. 12, pp. 2313-2330, 1999.
40. E. A. Gould, A. Buckley, N. Cammack et al., "Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies, " Journal of General Virology, vol. 66, no. 7, pp. 1369-1382, 1985.
41. C. Puttikhunt, P. Keelapang, N. Khemnu, N. Sittisombut, W. Kasinrerk, and P. Malasit, "Novel anti-dengue monoclonal antibody recognizing conformational structure of the prM-E heterodimeric complex of dengue virus, " Journal ofMedical Virology, vol. 80, no. 1, pp. 125-133, 2008.